2007•Pharmaceutical biotechnologyRequires access

Study on the Preparation of Hepatitis B-BCG Combined Vaccine

Lijie Jin

Open publisher page 0 citations

Abstract

To prepare the Hepatitis B-BCG combined vaccine, the hepatitis B surface antigen( HBsAg)was prepared by genetic engineering technique and BCG was produced using routine biological technique, then the final product of the hepatitis B-BCG combined vaccine was processed by freeze-drying. The stability and efficacy on freeze-dry antigen were also studied .The immune response, safety,partial toxicity,and allergy were tested using different animals. Results found that the freeze-drying technique had no effect on antigen; also no significant difference in the relative efficacy among the combined vaccine or BCG(P0.05);The Hepatitis B vaccine was the same (P0.05); The safety in hepatitis B-BCG combined vaccine group was accorded with that in BCG group, and the tuberculosis was not seen. The process in pathological changes of hepatitis B-BCG combined vaccine group and BCG group was similar. HBsAg did not strengthen the inflammation reaction caused by BCG. In addition the allergy was not found in experment.

About this research paper

What this paper is about

To prepare the Hepatitis B-BCG combined vaccine, the hepatitis B surface antigen( HBsAg)was prepared by genetic engineering technique and BCG was produced using routine biological technique, then the final product of the hepatitis B-BCG combined vaccine was processed by freeze-drying. The stability and efficacy on freeze-dry antigen were also studied .The immune response, safety,partial toxicity,and allergy were tested using different animals. Results found that the freeze-drying technique had no effect on antigen; also no significant difference in the relative efficacy among the combined vaccine or BCG(P0.05);The Hepatitis B vaccine was the same (P0.05); The safety in hepatitis B-BCG combined vaccine group was accorded with that in BCG group, and the tuberculosis was not seen. The process in pathological changes of hepatitis B-BCG combined vaccine group and BCG group was similar. HBsAg did not strengthen the inflammation reaction caused by BCG. In addition the allergy was not found in experment.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

To prepare the Hepatitis B-BCG combined vaccine, the hepatitis B surface antigen( HBsAg)was prepared by genetic engineering technique and BCG was produced using routine biological technique, then the final product of the hepatitis B-BCG combined vaccine was processed by freeze-drying. The stability and efficacy on freeze-dry antigen were also studied .The immune response, safety,partial toxicity,and allergy were tested using different animals. Results found that the freeze-drying technique had no effect on antigen; also no significant difference in the relative efficacy among the combined vaccine or BCG(P0.05);The Hepatitis B vaccine was the same (P0.05); The safety in hepatitis B-BCG combined vaccine group was accorded with that in BCG group, and the tuberculosis was not seen. The process in pathological changes of hepatitis B-BCG combined vaccine group and BCG group was similar. HBsAg did not strengthen the inflammation reaction caused by BCG. In addition the allergy was not found in experment.

Key concepts: HBsAg, Medicine, Hepatitis B vaccine, Hepatitis B, Antigen, Immunology, Tuberculosis, BCG vaccine

Related papers

Back to paper searchBrowse research topicsOriginal source
Study on the Preparation of Hepatitis B-BCG Combined Vaccine — Research Paper | ScholarLens